Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
By Mill Chart
Last update: Mar 22, 2024
What's going on in today's session
Top gainers
| Ticker | Change | Comment |
|---|---|---|
| BCAN | 13.0K% | BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) shares rose 13.0K% to $2.58. Shareholders saw the stock price going 90.54% lower in the past month. |
| ATER | 1.0K% | Investors celebrated as ATERIAN INC (NASDAQ:ATER) experienced a 1.0K% rise in its shares, closing at $3.59 during Friday's session. The stock is trading 26.77% lower than a month ago. |
| MBRX | 1.0K% | MOLECULIN BIOTECH INC's (NASDAQ:MBRX) shares rose 1.0K% to $5.38. In the last 3 months the share price dropped with 35.0%. |
| MLGO | 830.0% | MICROALGO INC's (NASDAQ:MLGO) stock price is advancing with 830.0% to a price of $4.0. In the last month the stock lost 44.81%. |
| CGC | 68.89% | Investors celebrated as CANOPY GROWTH CORP (NASDAQ:CGC) experienced a 68.89% rise in its shares, closing at $7.7 during Friday's session. In the last month the share price increased with 35.31%. |
| OTRK | 54.0% | ONTRAK INC (NASDAQ:OTRK) experienced a significant 54.0% increase, reaching $0.4 during Friday's session. Two days ago the company had a press release: Ontrak Health Announces the Launch of the Ontrak Advanced Engagement System, Ushering in the Next Era of AI-enabled Behavioral Healthcare. |
| VERBW | 46.12% | Exciting news for VERB TECHNOLOGY CO INC-CW24 (NASDAQ:VERBW) as its stock price surged 46.12% to $0.07 during Friday's session. The stock is trading 419.0% higher than a month ago. |
| VERI | 34.33% | VERITONE INC (NASDAQ:VERI) experienced a significant 34.33% increase, reaching $4.93 during Friday's session. The stock is trading 88.69% higher than a month ago. |
| VIRI | 28.1% | VIRIOS THERAPEUTICS INC (NASDAQ:VIRI) experienced a significant 28.1% increase, reaching $0.42 during Friday's session. The stock is trading 44.43% lower than 3 months ago. |
| IMCC | 27.12% | IM CANNABIS CORP's (NASDAQ:IMCC) shares rose 27.12% to $0.37. Shareholders saw the stock price going 49.96% lower is the past 6 months. |
To see the full list of top gainers you can use our top gainers page.
Today's top losers
| Ticker | Change | Comment |
|---|---|---|
| SWVL | -33.79% | The market experienced a 33.79% downturn in SWVL HOLDINGS CORP's (NASDAQ:SWVL) stock price, closing at $9.6 during Friday's session. In the last month the stock gained 223.0%. |
| NKTX | -32.86% | NKARTA INC's (NASDAQ:NKTX) stock price encountered a 32.86% decline, reaching $8.71 during Friday's session. Shareholders saw the stock price going 36.63% higher in the past month. |
| SINT | -31.91% | The market experienced a downward movement in SINTX TECHNOLOGIES INC's (NASDAQ:SINT) stock price, closing at $0.09 with a 31.91% decrease during Friday's session. The stock is trading 71.06% lower than 3 months ago. |
| CUTR | -29.57% | There was a notable decline in CUTERA INC's (NASDAQ:CUTR) shares, as they dropped 29.57% to $1.62 during Friday's session. A press release (Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook) was released yesterday. |
| RETO | -27.27% | RETO ECO-SOLUTIONS INC (NASDAQ:RETO) encountered a 27.27% decrease in its shares, reaching $1.36 during Friday's session. Two days ago the company had a press release: ReTo Regained Compliance with Nasdaq's Minimum Bid Price Requirement and Received Extension on Compliance with Nasdaq's Minimum Stockholders' Equity Rule. |
| SGMO | -23.6% | Investors witnessed a 23.6% decrease in SANGAMO THERAPEUTICS INC's (NASDAQ:SGMO) stock price, which closed at $0.74 during Friday's session. Earlier today the company had a press release: Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering. |
| ATNF | -21.54% | 180 LIFE SCIENCES CORP's (NASDAQ:ATNF) stock price is declining with 21.54% to a price of $2.73. In the last 6 months the stock lost 67.91%. |
| EGOX | -21.27% | There was a notable decline in NEXT.E.GO NV's (NASDAQ:EGOX) shares, as they dropped 21.27% to $0.04 during Friday's session. The stock is trading 61.19% lower than a month ago. |
| GNS | -21.15% | The market experienced a 21.15% downturn in GENIUS GROUP LTD's (NYSEARCA:GNS) stock price, closing at $0.41 during Friday's session. In the last month the stock gained 51.25%. |
| SOUNW | -20.12% | SOUNDHOUND AI INC's (NASDAQ:SOUNW) stock price faced a 20.12% decline, reaching $2.74 during Friday's session. In the last month the stock gained 29.43%. |
For the full top loser list go to our top losers page.
SANGAMO THERAPEUTICS INC
NASDAQ:SGMO (5/10/2024, 10:47:02 AM)
0.557
+0.04 (+7.12%)
SGMO News
15 hours ago - InvestorPlaceSGMO Stock Earnings: Sangamo Therapeutics Misses EPS, Misses Revenue for Q1 2024SGMO stock results show that Sangamo Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
15 hours ago - BusinessInsiderSGMO Stock Earnings: Sangamo Therapeutics Misses EPS, Misses Revenue for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sangamo Therapeutics (NASDAQ:SGMO) just reported results for the first quarter ...
20 hours ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
a day ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
8 days ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
18 days ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)18 days ago - Market News VideoNotable Monday Option Activity: MTTR, IBM, SGMO
2 months ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
2 months ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
2 months ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs
2 months ago - Sangamo Therapeutics, Inc.Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast
3 months ago - Seeking AlphaSangamo stock soars 37% on updates for Fabry disease therapy (NASDAQ:SGMO)Sangamo Therapeutics (SGMO) stock rallied 37% Monday after the biotech company announced regulatory updates for its gene therapy candidate ST-920 in the treatme
